PepGen (PEPG) Cash from Investing Activities (2021 - 2026)
PepGen (PEPG) posted Cash from Investing Activities of -$1.5 million for Q1 2026, up 97.8% sequentially from -$66.2 million in Q4 2025, and down 108.51% YoY from $17.1 million in Q1 2025.
Analysis
PepGen (PEPG) Cash from Investing Activities (2021 - 2026) Analysis & Trends
PepGen has reported Cash from Investing Activities for 6 years, with the latest figure at -$1.5 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 108.51% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.8 million (down 266.78% YoY) and the FY2025 annual result came in at -$15.2 million, up 59.55% from the prior year.
- Cash from Investing Activities grew to -$1.5 million in Q1 2026 per PEPG's latest filing, from -$66.2 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $26.5 million in Q4 2024 and troughed at -$66.2 million in Q4 2025.
- A 5-year average of -$5.3 million and a median of -$1.0 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 5127.35% in 2024, then surged 14312.78% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$1.1 million in 2022, then slumped by 2584.94% to -$29.6 million in 2023, then surged by 189.57% to $26.5 million in 2024, then slumped by 349.97% to -$66.2 million in 2025, then surged by 97.8% to -$1.5 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$1.5 million, -$66.2 million, and $18.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | -3.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.52 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -66.24 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 14.96 Mn |
| Mar 31, 2025 | 17.15 Mn |
| Dec 31, 2024 | 26.50 Mn |
| Sep 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -52.74 Mn |
| Mar 31, 2024 | -11.29 Mn |
| Dec 31, 2023 | -29.59 Mn |
| Sep 30, 2023 | -225,000.00 |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -1.18 Mn |
| Dec 31, 2022 | -1.10 Mn |
| Sep 30, 2022 | -430,000.00 |
| Jun 30, 2022 | -609,000.00 |
| Mar 31, 2022 | -1.61 Mn |
| Dec 31, 2021 | -156,000.00 |
| Sep 30, 2021 | -24,000.00 |